Exicure

Exicure is a company listed under the stock ticker XCUR (US).

View the org chart displaying its 6 main executives

Most searched biographies at Exicure

• Paul Kang, Director and Chief Executive Officer
• Hyuk Joon Ko, Director
• Hojoon Lee, Director

Popular executive movements at Exicure

• Jung-Sang Kim, Director, Chief Executive Officer and Chief Financial Officer, has left the company  (posted on August 24 2023).
• Paul Kang, who was Director, is promoted to Director and Chief Executive Officer  (posted on August 24 2023).
• Jiyoung Hwang, who was Director, is promoted to Chief Financial Officer and Director  (posted on August 24 2023).

Create your alert
to follow the executive moves at Exicure.

Exicure has 2,281 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Exicure

• Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis
• Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors
• Exicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update
• Exicure, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update
• Exicure, Inc. Announces Support of CEO in its Ongoing Exploration of Strategic Alternatives
• Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q
• Exicure, Inc. Announces Investment in Korean SNS Platform Cyworld
• Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors
• Exicure, Inc. Reports Full Year 2022 Financial Results and Provides Corporate Update
• Exicure, Inc. Announces Closing of Private Placement Transaction with CBI USA, Inc. and Changes to the Board of Directors
• View more press releases Close

Social media about Exicure

• Exicure on Wikipedia, Google News & Yahoo Finance
• Exicure on LinkedIn, Twitter & YouTube

Contact by email its executives including Paul Kang

Call Exicure at +1 847...

View the org chart

Register to receive your alert

Report an error